Series A - Superfluid Dx
Investment Firm
Overview
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Announced Date
Dec 20, 2023
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Alzheimer's Drug Discovery Foundation |
Round Details and Background
Superfluid Dx raised an undisclosed amount on 2023-12-20 in Series A
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 07, 2022 |  Grant - Superfluid Dx | 1 | - | undefined |
| Dec 20, 2023 | Series A - Superfluid Dx | 2 | - | undefined |
| Jan 05, 2017 | Seed Round - Superfluid Dx | 4 | - | 8.2M |
Recent Activity
There is no recent news or activity for this profile.